Sanofi (SNY) News Today $50.90 +0.76 (+1.52%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$50.79 -0.11 (-0.22%) As of 10/3/2025 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period UBS Reaffirms Their Buy Rating on Sanofi (SNYNF)October 4 at 7:32 AM | theglobeandmail.comHilltop National Bank Makes New $662,000 Investment in Sanofi $SNYOctober 4 at 4:25 AM | marketbeat.comPatriot Financial Group Insurance Agency LLC Has $1.45 Million Stock Position in Sanofi $SNYOctober 4 at 4:15 AM | marketbeat.comLeerink Partnrs Has Negative Outlook for Sanofi Q4 EarningsOctober 4 at 2:31 AM | americanbankingnews.comMatauro LLC Invests $1.85 Million in Sanofi $SNYOctober 3 at 5:32 AM | marketbeat.comSanofi $SNY Shares Bought by Janney Montgomery Scott LLCOctober 3 at 3:38 AM | marketbeat.comLeerink Partnrs Issues Negative Forecast for Sanofi EarningsOctober 2 at 7:46 AM | marketbeat.comSanofi raided by EU in flu vaccines antitrust probe, FT reportsOctober 1 at 10:44 PM | msn.comSanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy RatingOctober 1 at 8:30 PM | insidermonkey.comLeerink Partnrs Has Negative Outlook of Sanofi Q3 EarningsOctober 1 at 6:02 AM | marketbeat.comSanofi (NASDAQ:SNY) Hits New 1-Year Low - Here's WhySeptember 30, 2025 | marketbeat.com12 Best Widow and Orphan Stocks to Buy According to AnalystsSeptember 29, 2025 | insidermonkey.comBank of America Securities Maintains Buy on Sanofi (SNY)September 29, 2025 | msn.comSanofi $SNY Shares Purchased by Wealth Enhancement Advisory Services LLCSeptember 27, 2025 | marketbeat.comSanofi’s SAR446268 Gains Fast Track Designation and Boosts Biotech InvestmentsSeptember 26, 2025 | msn.comSanofi announces broad expansion of Insulins Valyou Savings ProgramSeptember 26, 2025 | msn.comSanofi (NASDAQ:SNY) Sees Strong Trading Volume - What's Next?September 26, 2025 | marketbeat.comSanofi Expands Insulin Savings Program To Cover All US PatientsSeptember 26, 2025 | benzinga.comSanofi Expands Insulin Savings Program To Cover All US PatientsSeptember 26, 2025 | benzinga.comSanofi to offer all insulin products for $35 per month in USSeptember 26, 2025 | reuters.comSanofi expands patient affordability program by offering access to all its insulins for $35 per month in the USSeptember 26, 2025 | prnewswire.comTrump’s 100% drug tariffs send pharma stocks lowerSeptember 26, 2025 | msn.comBallentine Partners LLC Lowers Stock Holdings in Sanofi $SNYSeptember 26, 2025 | marketbeat.comSanofi ordered to pay over $177M in France over anticompetitive behaviorSeptember 24, 2025 | msn.comFrench court orders Sanofi to pay $177 million for anti-competitive behaviourSeptember 24, 2025 | reuters.comCGN Advisors LLC Acquires Shares of 35,072 Sanofi $SNYSeptember 24, 2025 | marketbeat.comPress Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovationSeptember 24, 2025 | globenewswire.comPress release: Availability of the Q3 2025 Aide mémoireSeptember 24, 2025 | globenewswire.comPress Release: Sanofi's SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1September 23, 2025 | globenewswire.comSeaCrest Wealth Management LLC Purchases New Holdings in Sanofi $SNYSeptember 22, 2025 | marketbeat.comPress Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosisSeptember 22, 2025 | globenewswire.comPress Release: Sanofi and Regeneron's Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinionSeptember 21, 2025 | globenewswire.comContravisory Investment Management Inc. Decreases Stake in Sanofi $SNYSeptember 19, 2025 | marketbeat.comVoya Investment Management LLC Increases Stock Holdings in Sanofi $SNYSeptember 17, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Shares Acquired Rep. Lisa C. McClainSeptember 17, 2025 | marketbeat.comPress Release: EADV: Sanofi's brivekimig achieved positive results in hidradenitis suppurativa in phase 2a studySeptember 17, 2025 | globenewswire.comLeerink Partners Maintains a Buy Rating on Sanofi (SNY)September 15, 2025 | msn.com9,344 Shares in Sanofi $SNY Purchased by 1248 Management LLCSeptember 14, 2025 | marketbeat.comIntegrity Alliance LLC. Invests $706,000 in Sanofi $SNYSeptember 14, 2025 | marketbeat.comAscent Group LLC Takes $426,000 Position in Sanofi $SNYSeptember 14, 2025 | marketbeat.comGoldman Sachs Group Inc. Lowers Stock Position in Sanofi $SNYSeptember 14, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Receives Average Rating of "Buy" from AnalystsSeptember 14, 2025 | marketbeat.comZimmer Partners LP Sells 126,700 Shares of Sanofi $SNYSeptember 11, 2025 | marketbeat.comPress Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degenerationSeptember 11, 2025 | markets.businessinsider.comPress Release: Sanofi's SAR402663 earns fast track designation in the US for neovascular age-related macular degenerationSeptember 11, 2025 | globenewswire.comSanofi (NASDAQ:SNY) Short Interest Up 35.2% in AugustSeptember 10, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Upgraded to Overweight at Morgan StanleySeptember 10, 2025 | marketbeat.comMandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®September 10, 2025 | prnewswire.comSanofi’s Tzield approved in China to delay type 1 diabetes progressionSeptember 10, 2025 | msn.comAmundi Sells 289,018 Shares of Sanofi $SNYSeptember 10, 2025 | marketbeat.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.530.53▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼2024▲SNY Articles Average Week Get the Latest News and Ratings for SNY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sanofi and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NVS News NVO News AZN News GSK News TAK News ARGX News ONC News INSM News BNTX News TEVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNY Stock Alerts